You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
澳門第二次全民核檢基本完成 暫未發現感染
澳門新型冠狀病毒感染應變協調中心表示,澳門第二次全民核酸檢測基本完成,從9月25日下午三時開始至昨(27日)晚上九時,採樣65.09萬人,47.27萬人已有檢測結果,均呈陰性;此外,自9月24日下午三時至9月25日下午三時有4.45萬人自行前往進行核酸檢測且不在全民核酸檢測計劃內,檢測結果均為陰性。兩者累計採樣69.54萬人,累計檢測51.72萬人,結果均呈陰性。
總結第一次全民核酸檢測首24小時的核酸採樣共28.25萬人;首48小時累計核酸採樣共53.64萬人;第二次全民核酸檢測首24小時的核酸採樣共25.32萬人,首48小時累計核酸採樣共56.29萬,兩次全民核檢的採樣進度相若。(wl/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.